Literature DB >> 27686027

Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.

Stephen M Stahl.   

Abstract

Parkinson's disease psychosis (PDP) is theoretically a serotonin-dopamine imbalance syndrome due to disruption of the normal balance between the serotonergic and dopaminergic neurotransmitter systems in key brain circuits.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27686027     DOI： 10.1017/S1092852916000602

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


  7 in total

1.  Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease.

Authors:  Briana R De Miranda; J Timothy Greenamyre
Journal:  Environ Sci Process Impacts       Date:  2020-01-30       Impact factor: 4.238

2.  Multiplexed Monitoring of Neurochemicals via Electrografting-Enabled Site-Selective Functionalization of Aptamers on Field-Effect Transistors.

Authors:  Zan Gao; Guangfu Wu; Yang Song; Huijie Li; Yuxuan Zhang; Michael J Schneider; Yingqi Qiang; Jackson Kaszas; Zhengyan Weng; He Sun; Bryan D Huey; Rebecca Y Lai; Yi Zhang
Journal:  Anal Chem       Date:  2022-06-09       Impact factor: 8.008

3.  Simultaneous serotonin and dopamine monitoring across timescales by rapid pulse voltammetry with partial least squares regression.

Authors:  Cameron S Movassaghi; Katie A Perrotta; Hongyan Yang; Rahul Iyer; Xinyi Cheng; Merel Dagher; Miguel Alcañiz Fillol; Anne M Andrews
Journal:  Anal Bioanal Chem       Date:  2021-10-23       Impact factor: 4.142

4.  Identification of Potential Parkinson's Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network.

Authors:  Jie Liu; Dongdong Peng; Jinlong Li; Zong Dai; Xiaoyong Zou; Zhanchao Li
Journal:  Molecules       Date:  2022-07-26       Impact factor: 4.927

5.  Disentangling dyskinesia from parkinsonism in motor structures of patients with schizophrenia.

Authors:  Katrin Sakreida; Wei-Hua Chiu; Juergen Dukart; Simon B Eickhoff; Thomas Frodl; Christian Gaser; Michael Landgrebe; Berthold Langguth; Daniela Mirlach; Ioana-Sabina Rautu; Markus Wittmann; Timm B Poeppl
Journal:  Brain Commun       Date:  2022-07-23

Review 6.  Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms.

Authors:  Shuo Zhang; Yan Ma
Journal:  World J Psychiatry       Date:  2022-09-19

7.  Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature.

Authors:  Katie T B Touma; Daniel C Touma
Journal:  Ment Health Clin       Date:  2018-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.